Search Within

Taha Merghoub

  1. "Billel Gasmi"
Formats
  1. Meeting Abstract (9)
  2. Journal Article (8)
Groups
  1. Department of Medicine (17)
  2. GSK Faculty (17)
  3. Melanoma and Immunotherapeutics Service (17)
  4. Solid Tumor Oncology Division (17)
  5. Sloan Kettering Institute Postdocs (13)
  6. Biostatistics Service (8)

More Groups

People
  1. Billel Gasmi (17)
  2. Jedd Wolchok (16)
  3. Sadna Budhu (10)
  4. Cailian Liu (9)
  5. Roberta Zappasodi (9)
  6. Yanyun Li (9)

More People

Years
  1. 2021 (1)
  2. 2020 (2)
  3. 2019 (1)
  4. 2018 (5)
  5. 2017 (2)
  6. 2016 (3)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (4)
  2. Cancer Research (3)
  3. Journal of Immunology (2)
  4. Oncotarget (2)
  5. Advances in Cancer Research (1)
  6. Cancer Cell (1)

More Publications

Publishers
  1. Biomed Central Ltd (4)
  2. American Association for Cancer Research (3)
  3. Cell Press (2)
  4. Impact Journals (2)
  5. The American Association of Immunologists, Inc (2)
  6. Academic Press, Elsevier Inc (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T cell immunotherapies trigger neutrophil activation to eliminate tumor antigen escape variants
    Meeting Abstract

    Hirschhorn, D.; Budhu, S.; Schröder, D.; Kraehenbuehl, L.; Flammar, A. L.; Chow, A.; Schulze, I.; Schad, S.; Ricca, J.; Gasmi, B.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Overcoming immune resistance with rationally designed combination immunotherapy
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Sirard, C.; Qi, J.; Liu, C.; Li, Y.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Zhong, H.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • ILC2s amplify PD-1 blockade by activating tissue-specific cancer immunity
    Journal Article

    Moral, J. A.; Leung, J.; Rojas, L. A.; Ruan, J.; Zhao, J.; Sethna, Z.; Ramnarain, A.; Gasmi, B.; Gururajan, M.; Redmond, D.; more...
    Nature (2020)

    Fulltext@MSK | Save
  • Tissue-specific innate lymphoid cells are novel targets for pancreatic cancer immunotherapy
    Meeting Abstract

    Leung, J.; Rojas, L. A.; Ruan, J.; Zhao, J.; Gasmi, B.; Sethna, Z.; Ramnarain, A.; Bhanot, U.; Askan, G.; Gururajan, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Defined factors overcome T-cell exhaustion via abscopal effect
    Meeting Abstract

    Khalil, D.; Campesato, L. F.; Budhu, S.; Li, Y.; Jones, C.; Suek, N.; Liu, C.; Gasmi, B.; Giese, R.; Pourpe, S.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Modulation of T(FH)-like cells and anti-tumor activity of immune checkpoint blockade
    Meeting Abstract

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • A delicate interplay between adaptive and innate immunity caused by immunotherapy triggers tumor immunity and aseptic inflammation
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; DeHanau, O.; Mangarin, L. M.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal of Immunology (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save
  • Non-conventional inhibitory CD4(+)Foxp3(−)PD-1(hi) T cells as a biomarker of immune checkpoint blockade activity
    Journal Article

    Zappasodi, R.; Budhu, S.; Hellmann, M. D.; Postow, M. A.; Senbabaoglu, Y.; Manne, S.; Gasmi, B.; Liu, C.; Zhong, H.; Li, Y.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects
    Meeting Abstract

    Hirschhorn, D.; Ricca, J.; Gasmi, B.; Mangarin, L. M.; De Henau, O.; Budhu, S.; Li, Y.; Cortez, C.; Xia, Y.; Zhong, H.; more...
    Journal for ImmunoTherapy of Cancer (2017)

    Fulltext@MSK | Save